Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DSSTox_CID_29382

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_29382

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection, USP
    Nexus Pharmaceuticals Receives FDA Approval for Procainamide HCL Injection, USP

    19 Oct 2017

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nexus-pharmaceuticals-receives-fda-approval-for-procainamide-hcl-injection-usp-300540005.html

    PR NEWSWIRE
    19 Oct 2017
    Share Share
    Nexus Pharm’s Generic Procainamide Hydrochloride Receives Approval In US
    Nexus Pharm’s Generic Procainamide Hydrochloride Receives Approval In US

    12 Oct 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206332

    FDA
    12 Oct 2017
    Share Share